Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fundamental and clinical studies on cefuzonam (
CZON
, L-105), a new oxime type cephalosporin, were performed and the results obtained are summarized below: 1. Concentrations of
CZON
were determined in serum, internal genital organs and retroperitoneal fluid after a single intravenous administration of 1 g dose. The peripheral serum level of
CZON
was 74.0 micrograms/ml at 15 minutes after the administration. A sufficient transfer of
CZON
into internal genital organs and retroperitoneal fluid was demonstrated. 2. In clinical trial,
CZON
was given to 11 cases with obstetrical and gynecological infections. Efficacies were evaluated as good in 9 cases and poor in 2 cases. No side effects were observed in any of the cases treated with
CZON
. In laboratory examinations, transient elevation of serum GOT, GPT and
alkaline phosphatase
was noted in 1 case.
...
PMID:[Fundamental and clinical studies on cefuzonam in the field of obstetrics and gynecology]. 366 86
